Page last updated: 2024-08-17

folic acid and Cancer of Prostate

folic acid has been researched along with Cancer of Prostate in 103 studies

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.91)18.7374
1990's3 (2.91)18.2507
2000's27 (26.21)29.6817
2010's56 (54.37)24.3611
2020's14 (13.59)2.80

Authors

AuthorsStudies
Augustin, E; Bujak, P; Kasprzak, A; Kowalczyk, A; Kowalik, P; Nowicka, AM; Paluszkiewicz, E; Pilch, J1
Ghanem, E; Hage, RE; Minassian, G; Rahme, K1
Chen, J; Chen, X; Deng, H; Hao, S; Wang, Y; Zhai, D; Zhou, Y1
Chen, J; Liu, S; Wang, Y; Xu, Y1
Chibane, AA; Khelil, M; Mouhoub-Terrab, R1
Gul, AR; Kailasa, SK; Kim, MW; Le, TN; Oh, KT; Park, TJ; Phan, LMT1
Appelhans, D; Boye, S; Daeg, J; Janke, A; Lederer, A; Shi, X; Temme, A; Voit, B; Xu, X; Zhao, J; Zhao, L1
Changizi, O; Keyvan Rad, J; Khoei, S; Mahdavi, SR; Mahdavian, A; Shirvalilou, S1
Banerjee, T; Bean, R; Butcher, T; Patel, A; Santra, S; Shaw, Z1
Moyad, MA1
Mirsafaei, R; Mirsattari, SN; Varshosaz, J1
Ashcraft, K; Bacich, D; Liss, MA; Satsangi, A1
DeCarlo, A; Malardier-Jugroot, C; Szewczuk, MR1
Baeza, A; Lopez, V; Rodríguez-García, V; Vallet-Regí, M; Villegas, MR1
Bacich, DJ; Balarin, A; Gutierrez, JM; Liss, MA; Lobitz, CA; O'Keefe, DS; Ullevig, SL1
Campos-Outcalt, D1
Ebrahimi, A; Hosseinzadeh Colagar, A; Karimian, M1
Bastiaansen, JAM; Bonvin, D; Hofmann, H; Mionić Ebersold, M; Stuber, M1
Darcy, R; Evans, JC; Hollier, BG; Malhotra, M; Nelson, CC; O'Driscoll, CM; Sweeney, K1
Buys, SS; Gren, LH; Hashibe, M; Kawakita, D; La Vecchia, C; Lee, YA1
Emerling, BM; Palamiuc, L1
Arellano, DL; Chauhan, K; Fournier, PGJ; Hirata, GA; Jain, A; Juárez, P; Sengar, P; Verdugo-Meza, A1
Bacich, DJ; Heston, WDW; Huang, SS; O'Keefe, DS1
Lillard, JW; Singh, R; Singh, SK1
Amitay, Y; Gabizon, A; Kumar, S; Ohana, P; Patil, Y; Shmeeda, H1
Rajput, SJ; Saroj, S1
Ahmad, I; Ain, MR; Ibrahim, IAA; Md, S; Nassir, AM; Shahzad, N; Waris, M1
Essén, A; Garmo, H; Hammar, N; Holmberg, L; Jungner, I; Malmström, H; Santaolalla, A; Van Hemelrijck, M; Walldius, G1
Bjørge, T; de Vogel, S; Fredriksen, Å; Meyer, K; Nygård, O; Tell, GS; Tretli, S; Ueland, PM; Ulvik, A; Vollset, SE1
Abdeen, S; Alexander, P; Bhagat, M; Chavali, M; Praseetha, PK; Rose, PA1
Han, YY; Song, JY; Talbott, EO1
Collin, SM1
Bacich, DJ; O'Keefe, DS; Rycyna, KJ1
Carroll, PR; Chan, JM; Davies, BJ; O'Keefe, DS; Richman, EL; Sadetsky, N; Tomaszewski, JJ1
Andrici, J; Cox, MR; Eslick, GD; Tio, M1
Huang, JY; Wang, JN; Wang, R; Zhang, AQ; Zheng, Y; Zhou, YH1
Banerjee, S; Jain, NK; Kesharwani, P; Mehra, NK; Singh, R; Singh, S1
Hu, QF; Sun, FV; Xia, GW1
Haldar, MK; Karandish, F; Katti, DR; Katti, KS; Mallik, S; Molla, MS1
Albanes, D; Allen, NE; Appleby, PN; Barricarte Gurrea, A; Bjørge, T; Bueno-de-Mesquita, HB; Chen, C; de Vogel, S; Donovan, J; Gislefoss, R; Goodman, G; Gunter, M; Hamdy, FC; Johansson, M; Key, TJ; King, IB; Kühn, T; Männistö, S; Martin, RM; Meyer, K; Neal, DE; Neuhouser, ML; Nygård, O; Price, AJ; Stattin, P; Tell, GS; Travis, RC; Trichopoulou, A; Tumino, R; Ueland, PM; Ulvik, A; Vollset, SE; Weinstein, SJ1
Guo, J; Holmes, JD; O'Driscoll, CM; Rahme, K1
Darcy, R; Evans, JC; Griffin, BT; Guo, J; Hanrahan, K; Landry, WD; Malhotra, M; O'Driscoll, CM; O'Neill, A; O'Shea, JP; Watson, RW1
Chang, X; Chao, Z; Zheng-Yan, G1
Choi, EH; Choi, KH; Jung, JS; Malkinski, L; Nam, KC; Park, BJ1
Adam, V; Eckschlager, T; Guran, R; Heger, Z; Kizek, R; Kopel, P; Kulich, P; Masarik, M; Merlos Rodrigo, MA; Polanska, H; Stiborova, M1
Chen, RC; Ji, J; Liu, N; Lu, W; Qiu, H; Shao, Z; Wang, J; Yao, H; Zhang, L; Zhang, X1
Bacich, DJ; Cummings, JL; O'Keefe, DS; Sobek, KM1
Amato, RJ; Hartmann, LC; He, W; Kalli, KR; Klee, GG; Kularatne, SA; Low, PS; Prendergast, FG1
Coogan, P; Palmer, JR; Rosenberg, L; Strom, BL; Zhang, Y1
Albanes, D1
Kristal, AR; Lippman, SM1
Baron, JA; Bresalier, RS; Burke, CA; Figueiredo, JC; Grau, MV; Haile, RW; McKeown-Eyssen, GE; Sandler, RS; Summers, RW1
Jiang, R; Yuan, S; Zhang, XN; Zhang, Y; Zhao, XH; Zu, YG1
Al Olama, AA; Benediktsdottir, KR; Chen, L; Collin, SM; Cox, A; Davis, M; Donovan, J; Easton, DF; Eeles, RA; Gudmundsson, J; Guy, M; Hamdy, FC; Kote-Jarai, Z; Lane, JA; Lewis, SJ; Martin, RM; Metcalfe, C; Morrison, J; Neal, DE; Rafnar, T; Smith, GD; Stefansson, K; Sulem, P; Zuccolo, L1
Bacich, DJ; Berkman, CE; Choi, JK; O'Keefe, DS; Yao, V1
Farris, P; Forester, A; Garzotto, M; Palma, A; Peters, L; Phoutrides, E; Shannon, J; Tillotson, CJ1
Baron, JA; Bønaa, KH; Chen, L; Collin, SM; Davis, M; Donovan, JL; Ebbing, M; Grau, MV; Hamdy, FC; Harris, R; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Nygård, O; Refsum, H; Smith, AD; Smith, GD; Ueland, PM; Zuccolo, L1
Safarinejad, MR; Safarinejad, S; Shafiei, N1
Colditz, GA; Wei, EK; Wolin, KY1
Ambrosini, GL; Beilby, J; de Klerk, NH; Musk, AW; Rossi, E1
Caberto, C; Cao, X; Harris, R; Hennis, AJ; Leske, MC; Nemesure, B; Pakseresht, M; Sharma, S; Wilkens, LR; Wu, SY1
Collin, SM; Cox, A; Davis, M; Donovan, JL; Hamdy, FC; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Refsum, H; Smith, AD; Smith, GD1
Bu, R; Cai, D; Chen, X; Cheng, Y; Liu, X; Ning, L; Pan, C; Wang, K; Wu, B1
Jiang, R; Li, J; Zhang, Y; Zhang, Z; Zhao, D; Zhao, X; Zu, Y1
Luka, Z; Wagner, C1
Bacich, DJ; Cummings, JL; Dhir, R; Mason, JB; Nelson, JB; O'Keefe, DS; Parwani, AV; Tomaszewski, JJ1
Bennett, FI; Jackson, MD; Walker, SP; Younger, NM1
Potter, JD1
Bakkar, A; Bismar, TA; Brockton, NT; Liu, S; Petersen, LF; Weljie, AM; Wen, J1
Bistulfi, G; Dhiman, VK; Foster, BA; Gillard, B; Karasik, E; Miecznikowski, J; Smiraglia, DJ1
Carducci, MA; Herman, JG; Shabbeer, S; Simons, BW; Williams, SA1
Akadam-Teker, AB; İsbir, T; Küçükhüseyin, Ö; Kurnaz, Ö; Narter, F; Yılmaz-Aydoğan, H1
Addlagatta, A; Digumarti, RR; Divyya, S; Gottumukkala, SR; Kumar, A; Kutala, VK; Murthy, PV; Naushad, SM; Rammurti, S; Reddy, ChR1
Baglietto, L; Bassett, JK; English, DR; Giles, GG; Hodge, AM; Hopper, JL; Severi, G1
Boyarskih, UA; Filipenko, ML; Ganov, DI; Lacarev, AF; Oskina, NA; Petrova, VD; Tonacheva, OG; Voronina, EN; Weiner, AS1
Cremers, P; Goldbohm, RA; Schouten, LJ; van den Brandt, PA; Verhage, BA1
Krupenko, NI; Krupenko, SA; Strickland, KC1
Addlagatta, A; Digumarti, RR; Divyya, S; Gottumukkala, SR; Kutala, VK; Murthy, PV; Naushad, SM; Reddy, ChR; Subbarao, SA1
Chen, GL; Epner, DE; Kwabi-Addo, B; Lu, S; Ren, C1
Horne, DW; Reed, KA2
BEMM, H; ROTZSCH, W; STRACK, E1
Albanes, D; Barrett, MJ; Hartman, TJ; Pietinen, P; Stolzenberg-Solomon, R; Taylor, PR; Virtamo, J; Weinstein, SJ1
Ghosh, A; Heston, WD1
Hattori, Y; Maitani, Y2
Bergh, A; Hallmans, G; Hultdin, J; Stattin, P; Van Guelpen, B1
Franceschi, S; Galeone, C; La Vecchia, C; Montella, M; Negri, E; Parpinel, M; Pelucchi, C; Talamini, R1
Bartholomew, H; Beilby, JP; Divitini, ML; Hung, J; Knuiman, MW; Rossi, E1
Bergh, AR; Hallmans, G; Hultdin, J; Stattin, PE; Van Guelpen, BR; Wirén, SM1
Calle, EE; McCullough, ML; Pavluck, AL; Rodriguez, C; Stevens, VL; Thun, MJ1
Albanes, D; Pietinen, P; Stolzenberg-Solomon, R; Taylor, PR; Virtamo, J; Weinstein, SJ1
van Guelpen, B1
Caballero, J; Carnero, J; Diaz, F; Gaitan, MJ; Machuca, J; Marchal, C; Perea-Milla, E; Redondo, M; Reyes-Engel, A1
Allen, NE; Appleby, PN; Ardanaz, E; Bingham, S; Boeing, H; Bueno-de-Mesquita, HB; Chirlaque, MD; Egevad, L; González, CA; Hallmans, G; Jenab, M; Johansson, M; Kaaks, R; Key, TJ; Khaw, KT; Kiemeney, LA; Larrañaga, N; Linseisen, J; Palli, D; Pischon, T; Psaltopoulou, T; Quirós, JR; Riboli, E; Rinaldi, S; Roddam, AW; Sánchez, MJ; Sieri, S; Stattin, P; Travis, RC; Trichopoulos, D; Trichopoulou, A; Tumino, R; Ueland, PM; Vineis, P; Vollset, SE1
Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H1
Berzin, TM; Heston, WD; Lin, S; May, F; Mukherjee, B; Pinto, JT; Qiao, CH; Suffoletto, BP; Tong, WP1
Andersson, C; O'Brien, NM; Wild, CP; Wilson, L; Woods, JA1
Krupenko, SA; Oleinik, NV1
Fairfield, KM; Fletcher, RH1
Andersson, A; Brattström, L; Hultberg, B; Israelsson, B; Olsson, A1
Jansen, SE; Joubert, M; Retief, FP1
Bloom, HJ; Wallace, DM; Williams, G1

Reviews

16 review(s) available for folic acid and Cancer of Prostate

ArticleYear
Effect of dietary antioxidants on the risk of prostate cancer. Systematic review and network meta-analysis.
    Nutricion hospitalaria, 2023, Jun-21, Volume: 40, Issue:3

    Topics: Antioxidants; Folic Acid; Humans; Male; Network Meta-Analysis; Prostatic Neoplasms; Vitamins

2023
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part II.
    Current urology reports, 2020, Mar-18, Volume: 21, Issue:3

    Topics: Cardiovascular Diseases; Diet; Dietary Supplements; Fish Oils; Folic Acid; Food; Health Status; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Male; Prescription Drugs; Prostatic Neoplasms; Quality Control; Risk Reduction Behavior; Vitamin B 12

2020
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:7

    Topics: Diagnostic Imaging; Folic Acid; Glutamate Carboxypeptidase II; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Radiotherapy

2018
Folate and B12 in prostate cancer.
    Advances in clinical chemistry, 2013, Volume: 60

    Topics: Betaine; Diet; Dietary Supplements; Folic Acid; Homocysteine; Humans; Male; Meta-Analysis as Topic; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Vitamin B 12

2013
Opposing roles of folate in prostate cancer.
    Urology, 2013, Volume: 82, Issue:6

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Disease Progression; Folic Acid; Folic Acid Deficiency; Humans; Immunohistochemistry; Kallikreins; Male; Nutrition Surveys; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B Complex

2013
Folate intake and the risk of prostate cancer: a systematic review and meta-analysis.
    Prostate cancer and prostatic diseases, 2014, Volume: 17, Issue:3

    Topics: Diet; Dietary Supplements; Folic Acid; Humans; Male; Odds Ratio; Prostatic Neoplasms; Risk

2014
Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies.
    BMC public health, 2014, Dec-29, Volume: 14

    Topics: Carcinoma; Diet; Folic Acid; Humans; Incidence; Male; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk

2014
[Roles of folate metabolism in prostate cancer].
    Zhonghua nan ke xue = National journal of andrology, 2015, Volume: 21, Issue:7

    Topics: Dietary Supplements; Disease Progression; Folic Acid; Food, Fortified; Humans; Male; Nutrition Surveys; Nutritional Status; Prostatic Neoplasms

2015
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:9

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Case-Control Studies; Folic Acid; Genetic Predisposition to Disease; Glutamate Carboxypeptidase II; Glycine Hydroxymethyltransferase; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Methylenetetrahydrofolate Reductase (NADPH2); Minor Histocompatibility Antigens; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors

2009
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010, Volume: 19, Issue:6

    Topics: Aged; Case-Control Studies; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Transcobalamins; Vitamin B 12

2010
Time course of risk factors in cancer etiology and progression.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-10, Volume: 28, Issue:26

    Topics: Alcohol Drinking; Breast Neoplasms; Colorectal Neoplasms; Diet; Disease Progression; Female; Folic Acid; Humans; Lung Neoplasms; Male; Neoplasms; Prognosis; Prostatic Neoplasms; Risk Factors; Smoking

2010
Molecular mechanisms underlying the potentially adverse effects of folate.
    Clinical chemistry and laboratory medicine, 2013, Mar-01, Volume: 51, Issue:3

    Topics: Cell Transformation, Neoplastic; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Humans; Male; Neoplasm Metastasis; Neoplasms; Neural Tube Defects; Prostatic Neoplasms; Tetrahydrofolate Dehydrogenase

2013
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
    Journal of cellular biochemistry, 2004, Feb-15, Volume: 91, Issue:3

    Topics: Alternative Splicing; Animals; Antigens, Surface; Contractile Proteins; Dipeptides; Endocytosis; Enhancer Elements, Genetic; Filamins; Folic Acid; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Humans; Male; Mice; Microfilament Proteins; Models, Biological; Prostatic Neoplasms; Receptors, Androgen

2004
Folate in colorectal cancer, prostate cancer and cardiovascular disease.
    Scandinavian journal of clinical and laboratory investigation, 2007, Volume: 67, Issue:5

    Topics: Colorectal Neoplasms; Female; Folic Acid; Folic Acid Deficiency; Humans; Male; Myocardial Infarction; Prostatic Neoplasms; Sweden; Vitamin B Complex

2007
A critical evaluation of the application of biomarkers in epidemiological studies on diet and health.
    The British journal of nutrition, 2001, Volume: 86 Suppl 1

    Topics: Biomarkers; Colorectal Neoplasms; Cooking; Diet; Epidemiologic Factors; Estrogens, Non-Steroidal; Female; Folic Acid; Genetic Predisposition to Disease; Genistein; Health Surveys; Heterocyclic Compounds; Humans; Iodine; Isoflavones; Male; Meat; Middle Aged; Neural Tube Defects; Nutritional Status; Phytoestrogens; Plant Preparations; Predictive Value of Tests; Pregnancy; Prostatic Neoplasms; Risk Factors; Specimen Handling; Vitamin D

2001
Vitamins for chronic disease prevention in adults: scientific review.
    JAMA, 2002, Jun-19, Volume: 287, Issue:23

    Topics: Ascorbic Acid; Avitaminosis; Blood Coagulation; Breast Neoplasms; Carotenoids; Chronic Disease; Colorectal Neoplasms; Coronary Disease; Dietary Supplements; Female; Folic Acid; Fractures, Bone; Humans; Lung Neoplasms; Male; Neoplasms; Neural Tube Defects; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin B 12; Vitamin B 6; Vitamin D; Vitamin E; Vitamin K; Vitamins

2002

Trials

3 trial(s) available for folic acid and Cancer of Prostate

ArticleYear
Feasibility of dietary folic acid reduction intervention for men on active surveillance for prostate cancer.
    Clinical nutrition ESPEN, 2021, Volume: 44

    Topics: Feasibility Studies; Folic Acid; Humans; Male; Pilot Projects; Prostatic Neoplasms; Watchful Waiting

2021
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
    Journal of the National Cancer Institute, 2009, Mar-18, Volume: 101, Issue:6

    Topics: Adenoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Dietary Supplements; Double-Blind Method; Folic Acid; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Research Design; Surveys and Questionnaires; United States; Vitamin B Complex

2009
Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
    European journal of clinical nutrition, 2010, Volume: 64, Issue:10

    Topics: Aged; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Folic Acid; Humans; Lycopene; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E

2010

Other Studies

84 other study(ies) available for folic acid and Cancer of Prostate

ArticleYear
Foliate-Targeting Quantum Dots-
    International journal of molecular sciences, 2022, Jan-23, Volume: 23, Issue:3

    Topics: Acridines; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Lung; Lung Neoplasms; Male; Nanoconjugates; Nanostructures; Prostate; Prostatic Neoplasms; Quantum Dots

2022
Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
    Nanotheranostics, 2023, Volume: 7, Issue:2

    Topics: Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Polylysine; Prostatic Neoplasms; RNA, Small Interfering

2023
In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Polyethylene Glycols; Prostate; Prostatic Neoplasms

2023
No association between MTHFR gene C677T/A1298C polymorphisms, serum folate, vitamin B12, homocysteine levels, and prostate cancer in an Algerian population.
    Molecular genetics & genomic medicine, 2023, Volume: 11, Issue:9

    Topics: Case-Control Studies; Folic Acid; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prostatic Neoplasms; Vitamin B 12

2023
One-pot synthesis of carbon dots with intrinsic folic acid for synergistic imaging-guided photothermal therapy of prostate cancer cells.
    Biomaterials science, 2019, Dec-01, Volume: 7, Issue:12

    Topics: Antigens, Surface; Carbon; Cell Line, Tumor; Cell Proliferation; Cell Survival; Folic Acid; Glutamate Carboxypeptidase II; Humans; Hyperthermia, Induced; Indoles; Male; Microscopy, Fluorescence; Nanoparticles; Phototherapy; Polymers; Prostatic Neoplasms

2019
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine.
    Biomacromolecules, 2020, 01-13, Volume: 21, Issue:1

    Topics: Animals; Antigens, Surface; Avidin; Biotin; Chelating Agents; Contrast Media; Dendrimers; Diagnostic Imaging; ErbB Receptors; Folic Acid; Glutamate Carboxypeptidase II; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanomedicine; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2020
Enhanced radiosensitivity of LNCaP prostate cancer cell line by gold-photoactive nanoparticles modified with folic acid.
    Photodiagnosis and photodynamic therapy, 2020, Volume: 29

    Topics: Cell Line, Tumor; Cell Survival; Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Radiation Tolerance

2020
Pseudo-branched polyester copolymer: an efficient drug delivery system to treat cancer.
    Biomaterials science, 2020, Mar-17, Volume: 8, Issue:6

    Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Folic Acid; Humans; Male; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; PC-3 Cells; Polymers; Prostatic Neoplasms; Reactive Oxygen Species

2020
Folate-Targeted Polyacrylamide/Punicic Acid Nanomicelles for Flutamide Delivery in Prostate Cancer: Characterization, In Vitro Biological Evaluation, and its DFT Study.
    Recent patents on nanotechnology, 2020, Volume: 14, Issue:4

    Topics: Acrylic Resins; Cell Death; Cell Line, Tumor; Density Functional Theory; Drug Delivery Systems; Fluorescence; Flutamide; Folic Acid; Humans; Linolenic Acids; Male; Micelles; Molecular Conformation; Nanoparticles; Particle Size; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared

2020
Rise in serum folate after androgen deprivation associated with worse prostate cancer-specific survival.
    Urologic oncology, 2020, Volume: 38, Issue:8

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Animals; Disease Models, Animal; Folic Acid; Humans; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Prostatic Neoplasms; Retrospective Studies; Survival Rate

2020
Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
    Bioconjugate chemistry, 2021, 03-17, Volume: 32, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Folate Receptor 1; Folic Acid; Humans; Male; Nanomedicine; Polymers; Pregnancy; Prostatic Neoplasms; Protein Binding

2021
Janus-Type Mesoporous Silica Nanoparticles for Sequential Tumoral Cell and Mitochondria Targeting.
    Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2275

    Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mitochondria; Nanoparticles; Organophosphorus Compounds; Porosity; Prostatic Neoplasms; Silicon Dioxide

2021
USPSTF recommendations: A 2017 roundup.
    The Journal of family practice, 2017, Volume: 66, Issue:5

    Topics: Advisory Committees; Aspirin; Breast Feeding; Cardiovascular Diseases; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Latent Tuberculosis; Male; Mass Screening; Neural Tube Defects; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pregnancy; Primary Health Care; Primary Prevention; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Syphilis; United States; Vitamin B Complex

2017
Association of Human Methionine Synthase-A2756G Transition With Prostate Cancer: A Case-Control Study and in Silico Analysis.
    Acta medica Iranica, 2017, Volume: 55, Issue:5

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Alleles; Case-Control Studies; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Iran; Male; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prostatic Neoplasms

2017
Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
    Dalton transactions (Cambridge, England : 2003), 2017, Sep-26, Volume: 46, Issue:37

    Topics: Cell Line, Tumor; Cell Survival; Ferric Compounds; Folic Acid; Humans; Hyperthermia, Induced; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microscopy, Electron, Transmission; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared

2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.
    International journal of pharmaceutics, 2017, Oct-30, Volume: 532, Issue:1

    Topics: Cell Line, Tumor; Cyclodextrins; Folic Acid; Humans; Male; Nanoparticles; Neuropilin-1; Peptides; Prostatic Neoplasms; RNA, Small Interfering; Spheroids, Cellular; Zinc Finger E-box-Binding Homeobox 1

2017
The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    British journal of cancer, 2018, Volume: 118, Issue:2

    Topics: Aged; Cohort Studies; Colorectal Neoplasms; Diet; Early Detection of Cancer; Female; Folic Acid; Food, Fortified; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Prospective Studies; Prostatic Neoplasms; United States

2018
PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer.
    The Journal of experimental medicine, 2018, 01-02, Volume: 215, Issue:1

    Topics: Antigens, Surface; Folic Acid; Glutamic Acid; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptors, Metabotropic Glutamate

2018
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
    Journal of nanobiotechnology, 2018, Feb-27, Volume: 16, Issue:1

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Folic Acid; Luminescent Agents; Male; Mice; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Reactive Oxygen Species; Silicon Dioxide; Yttrium

2018
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
    Cancer letters, 2018, 07-28, Volume: 427

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Resveratrol

2018
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA).
    Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:4

    Topics: Antigens, Surface; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Folic Acid; Glutamate Carboxypeptidase II; Humans; Liposomes; Male; Mitomycin; Prostatic Neoplasms

2018
Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup3

    Topics: Cell Line, Tumor; Drug Carriers; Etoposide; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Silicon Dioxide

2018
Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: Invitro and invivo activity.
    Life sciences, 2019, Mar-01, Volume: 220

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Liberation; Folic Acid; Humans; Iridoid Glucosides; Iridoids; Liposomes; Male; Mice; Mice, Inbred BALB C; Particle Size; Prostatic Neoplasms

2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.
    Cancer causes & control : CCC, 2019, Volume: 30, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Diet; Female; Folic Acid; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk; Sweden; Vitamin B 12

2019
Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort.
    International journal of epidemiology, 2013, Volume: 42, Issue:1

    Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Folic Acid; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Norway; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Population Surveillance; Prospective Studies; Prostatic Neoplasms; Risk Factors; Socioeconomic Factors; Vitamin B 12

2013
Drug embedded PVP coated magnetic nanoparticles for targeted killing of breast cancer cells.
    Technology in cancer research & treatment, 2013, Volume: 12, Issue:5

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Coated Materials, Biocompatible; Drug Delivery Systems; Epirubicin; Female; Folic Acid; Humans; Leukemia; Lung Neoplasms; Magnetite Nanoparticles; Male; Pharmaceutic Aids; Povidone; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared

2013
Serum folate and prostate-specific antigen in the United States.
    Cancer causes & control : CCC, 2013, Volume: 24, Issue:8

    Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cross-Sectional Studies; Folic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Nutrition Surveys; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; United States

2013
Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.
    The Journal of urology, 2014, Volume: 191, Issue:4

    Topics: Adenocarcinoma; Aged; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Neoplasms

2014
Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Drug development and industrial pharmacy, 2015, Volume: 41, Issue:11

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Humans; Lactic Acid; Male; MCF-7 Cells; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Saquinavir

2015
Sequential culture on biomimetic nanoclay scaffolds forms three-dimensional tumoroids.
    Journal of biomedical materials research. Part A, 2016, Volume: 104, Issue:7

    Topics: Alkaline Phosphatase; Aluminum Silicates; Biomimetic Materials; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Cell Survival; Clay; Drug Delivery Systems; Folic Acid; Humans; Male; Mesenchymal Stem Cells; Nanoparticles; Osteoblasts; Osteogenesis; Prostatic Neoplasms; Spheroids, Cellular; Tissue Scaffolds; Tumor Cells, Cultured

2016
Circulating Folate and Vitamin B
    European urology, 2016, Volume: 70, Issue:6

    Topics: Aged; Case-Control Studies; Cohort Studies; Folic Acid; Hexetidine; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk; Vitamin B 12

2016
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
    International journal of pharmaceutics, 2016, Jul-25, Volume: 509, Issue:1-2

    Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Folic Acid; Gene Silencing; Gene Transfer Techniques; Genetic Therapy; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Prostate; Prostatic Neoplasms; RNA, Small Interfering

2016
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.
    Nanomedicine : nanotechnology, biology, and medicine, 2016, Volume: 12, Issue:8

    Topics: Cell Line, Tumor; Cyclodextrins; Folic Acid; Gene Silencing; Humans; Male; Nanoparticles; Prostatic Neoplasms; RNA, Small Interfering

2016
Re: Alison J. Price, Ruth C. Travis, Paul N. Appleby, et al. Circulating Folate and Vitamin B
    European urology, 2017, Volume: 71, Issue:1

    Topics: Folic Acid; Humans; Male; Prostatic Neoplasms; Risk; Vitamin B 12

2017
Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.
    Molecules (Basel, Switzerland), 2016, Sep-06, Volume: 21, Issue:9

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cobalt; Contrast Media; Ferric Compounds; Folic Acid; Hematoporphyrins; Humans; Magnetic Fields; Magnetic Resonance Imaging; Male; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms

2016
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes.
    Scientific reports, 2016, 09-20, Volume: 6

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Folic Acid; Humans; Liposomes; Male; Metallothionein; Mice; Models, Biological; Phosphatidylethanolamines; Prostatic Neoplasms; Sarcosine; Tumor Burden; Xenograft Model Antitumor Assays; Zinc

2016
Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.
    Nanomedicine : nanotechnology, biology, and medicine, 2017, Volume: 13, Issue:4

    Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Folic Acid; Humans; Male; Mice; Mice, Nude; Nanoparticles; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; RNA, Small Interfering; Xenograft Model Antitumor Assays

2017
Contrasting roles of the ABCG2 Q141K variant in prostate cancer.
    Experimental cell research, 2017, 05-01, Volume: 354, Issue:1

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Docetaxel; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasm Proteins; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Taxoids

2017
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
    International journal of cancer, 2008, Oct-15, Volume: 123, Issue:8

    Topics: Case-Control Studies; Double-Blind Method; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; KB Cells; Ligands; Male; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prostatic Neoplasms; Sensitivity and Specificity

2008
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.
    Cancer causes & control : CCC, 2009, Volume: 20, Issue:5

    Topics: Adult; Aged; beta Carotene; Case-Control Studies; Dietary Supplements; Folic Acid; Humans; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Vitamin E; Vitamins; Zinc

2009
Vitamin supplements and cancer prevention: where do randomized controlled trials stand?
    Journal of the National Cancer Institute, 2009, Jan-07, Volume: 101, Issue:1

    Topics: Antioxidants; Ascorbic Acid; beta Carotene; Colorectal Neoplasms; Confounding Factors, Epidemiologic; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Lung Neoplasms; Male; Neoplasms; Primary Prevention; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; United States; Vitamin B 12; Vitamin B 6; Vitamin E

2009
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
    Journal of the National Cancer Institute, 2009, Mar-18, Volume: 101, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Cohort Studies; Cooperative Behavior; Dietary Supplements; Folic Acid; Humans; Interdisciplinary Communication; Male; Prostatic Neoplasms; Research Design; Risk Factors; Vitamin B Complex

2009
[Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2009, Volume: 44, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine

2009
Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
    The Prostate, 2010, Feb-15, Volume: 70, Issue:3

    Topics: Antigens, Surface; Cell Line, Tumor; Cell Proliferation; Dipeptides; Folic Acid; Glutamate Carboxypeptidase II; Humans; Hydrolysis; Male; Organophosphorus Compounds; Prostatic Neoplasms; Pteroylpolyglutamic Acids

2010
Folate intake and prostate cancer risk: a case-control study.
    Nutrition and cancer, 2009, Volume: 61, Issue:5

    Topics: Aged; Aged, 80 and over; Alcohol Drinking; Biopsy; Body Mass Index; Case-Control Studies; Confidence Intervals; Diet; Diet Surveys; Folic Acid; Humans; Male; Matched-Pair Analysis; Middle Aged; Odds Ratio; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; United States; Veterans

2009
Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
    The Prostate, 2010, Nov-01, Volume: 70, Issue:15

    Topics: Adult; Aged; Case-Control Studies; Cystamine; DNA; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B 12

2010
Validation of a quantitative FFQ for the Barbados National Cancer Study.
    Public health nutrition, 2011, Volume: 14, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Barbados; Black People; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Diet; Diet Records; Diet Surveys; Dietary Fiber; Evaluation Studies as Topic; Feeding Behavior; Female; Folic Acid; Humans; Male; Middle Aged; Nutrition Assessment; Prostatic Neoplasms; Surveys and Questionnaires; Vitamin A; Vitamin B 12; Vitamin E; Vitamins

2011
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010, Volume: 19, Issue:11

    Topics: Aged; Biomarkers, Tumor; Disease Progression; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Vitamin B 12

2010
Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population.
    Journal of genetics, 2010, Volume: 89, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Aged, 80 and over; Alleles; Case-Control Studies; China; Ferredoxin-NADP Reductase; Folic Acid; Genetic Linkage; Genotype; Haplotypes; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prostatic Hyperplasia; Prostatic Neoplasms

2010
Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.
    International journal of nanomedicine, 2010, Sep-20, Volume: 5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cattle; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Folic Acid; Humans; In Vitro Techniques; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine; Solubility; Surface Properties

2010
Sarcosine, folate metabolism and prostate cancer--is there a link?
    The Journal of urology, 2011, Volume: 185, Issue:2

    Topics: Biomarkers, Tumor; Case-Control Studies; Folic Acid; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Reference Values; Sarcosine; Sensitivity and Specificity

2011
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate.
    The Prostate, 2011, Volume: 71, Issue:12

    Topics: Adult; Aged; Carcinoma; Cell Proliferation; Fasting; Folic Acid; Humans; Immunohistochemistry; Incidence; Ki-67 Antigen; Male; Middle Aged; Osmolar Concentration; Prostatic Neoplasms; Staining and Labeling

2011
Use of a food frequency questionnaire to assess diets of Jamaican adults: validation and correlation with biomarkers.
    Nutrition journal, 2011, Apr-09, Volume: 10

    Topics: Adult; Aged; Biomarkers; Calibration; Case-Control Studies; Cholesterol; Diet; Dietary Fats; Dietary Proteins; Energy Intake; Feeding Behavior; Female; Folic Acid; Humans; Jamaica; Male; Middle Aged; Prostatic Neoplasms; Regression Analysis; Reproducibility of Results; Surveys and Questionnaires; Vitamin A; Vitamin E

2011
New Zealand should have mandatory fortification of bread with folic acid: no.
    Journal of primary health care, 2010, Volume: 2, Issue:1

    Topics: Bread; Colorectal Neoplasms; Folic Acid; Food, Fortified; Humans; Male; Neural Tube Defects; New Zealand; Nutrition Policy; Prostatic Neoplasms; Risk

2010
Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells.
    BJU international, 2012, Volume: 109, Issue:5

    Topics: Cell Proliferation; Folic Acid; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Sarcosine; Tumor Cells, Cultured

2012
Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:11

    Topics: Animals; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; CpG Islands; Diet; Disease Models, Animal; Disease Progression; DNA Methylation; Folic Acid; Folic Acid Deficiency; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostate; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Messenger

2011
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Choline; Decitabine; Diet; Disease Progression; DNA Methylation; Folic Acid; Homocysteine; Humans; Male; Methionine; Mice; Mice, Nude; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin B 6

2012
Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:9

    Topics: Aged; Alleles; Binding Sites; Exons; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms

2011
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.
    Gene, 2012, Apr-15, Volume: 497, Issue:2

    Topics: Abortion, Spontaneous; Antigens, Surface; Autistic Disorder; Breast Neoplasms; Cohort Studies; Coronary Artery Disease; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Glutamate Carboxypeptidase II; Humans; Male; Polymorphism, Genetic; Prostatic Neoplasms

2012
Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality.
    Cancer causes & control : CCC, 2012, Volume: 23, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Australia; Cohort Studies; Confidence Intervals; Female; Folic Acid; Follow-Up Studies; Humans; Incidence; Male; Methionine; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Riboflavin; Risk Factors; Surveys and Questionnaires; Vitamin B Complex

2012
Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.
    Bulletin of experimental biology and medicine, 2012, Volume: 152, Issue:4

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Case-Control Studies; Folic Acid; Gene Frequency; Genetic Loci; Genotype; Glycine Hydroxymethyltransferase; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Siberia; White People

2012
Dietary folate and folate vitamers and the risk of prostate cancer in The Netherlands Cohort Study.
    Cancer causes & control : CCC, 2012, Volume: 23, Issue:12

    Topics: Aged; Cohort Studies; Folic Acid; Humans; Male; Middle Aged; Netherlands; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires

2012
Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
    Gene, 2013, Mar-01, Volume: 516, Issue:1

    Topics: Adult; Aged; Antigens, Surface; Breast Neoplasms; Case-Control Studies; Female; Folic Acid; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Haplotypes; Humans; Male; Middle Aged; Prostatic Neoplasms; Protein Conformation; Risk Factors; Young Adult

2013
Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.
    Biochemical pharmacology, 2003, Sep-01, Volume: 66, Issue:5

    Topics: Antimetabolites, Antineoplastic; Cell Division; Fluorouracil; Folic Acid; Humans; Male; Methionine; Nucleotides; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured

2003
Uptake of 5-methyltetrahydrofolate into PC-3 human prostate cancer cells is carrier-mediated.
    The Journal of nutritional biochemistry, 2003, Volume: 14, Issue:8

    Topics: Arsenates; Biological Transport; Carrier Proteins; Folic Acid; Humans; Hydrogen-Ion Concentration; Leucovorin; Male; Methotrexate; Phosphates; Prostatic Neoplasms; Sodium; Sodium Azide; Sodium Cyanide; Sulfates; Tetrahydrofolates; Tumor Cells, Cultured

2003
[TRIMETHYLAMINE AND TRIMETHYLAMINE OXIDE IN THE URINE AFTER THE ADMINISTRATION OF N-14- AND N-15-(-) CARNITINE].
    Acta biologica et medica Germanica, 1963, Volume: 11

    Topics: Amines; Body Fluids; Carnitine; Folic Acid; Humans; Hyperthyroidism; Male; Methylamines; Nitrogen; Prostatic Neoplasms; Radioisotopes; Urine; Vitamin B Complex

1963
Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:11 Pt 1

    Topics: Aged; Case-Control Studies; Diet; Dietary Supplements; DNA Methylation; DNA Repair; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin B 12; Vitamin B 6

2003
Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer.
    Journal of controlled release : official journal of the Controlled Release Society, 2004, May-31, Volume: 97, Issue:1

    Topics: Cell Line, Tumor; DNA; Folic Acid; Genetic Therapy; Humans; Male; Mouth Neoplasms; Nanostructures; Particle Size; Prostatic Neoplasms; Transfection

2004
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
    International journal of cancer, 2005, Feb-20, Volume: 113, Issue:5

    Topics: Adult; Aged; Bone Neoplasms; Case-Control Studies; Folic Acid; Homocysteine; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Sweden; Vitamin B 12

2005
Dietary folate and risk of prostate cancer in Italy.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005, Volume: 14, Issue:4

    Topics: Aged; Alcohol Drinking; Case-Control Studies; Diet; Energy Intake; Folic Acid; Folic Acid Deficiency; Humans; Italy; Logistic Models; Male; Middle Aged; Nutritional Status; Prostatic Neoplasms; Risk Factors

2005
Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
    Cancer gene therapy, 2005, Volume: 12, Issue:10

    Topics: Chromatography, High Pressure Liquid; Connexin 43; DNA Primers; Flow Cytometry; Fluorescein-5-isothiocyanate; Folic Acid; Gene Transfer Techniques; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Luciferases; Male; Nanostructures; Nasopharyngeal Neoplasms; Plasmids; Prostatic Neoplasms; Simplexvirus; Thymidine Kinase

2005
Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
    Annals of epidemiology, 2006, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Australia; Breast Neoplasms; Cohort Studies; Colorectal Neoplasms; Female; Folic Acid; Humans; Male; Middle Aged; Morbidity; Mortality; Neoplasms; Prospective Studies; Prostatic Neoplasms

2006
Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2006, Volume: 15, Issue:1

    Topics: Adult; Case-Control Studies; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Genetic; Prospective Studies; Prostatic Neoplasms; Risk; Sweden; Vitamin B 12

2006
Folate nutrition and prostate cancer incidence in a large cohort of US men.
    American journal of epidemiology, 2006, Jun-01, Volume: 163, Issue:11

    Topics: Aged; Diet; Folic Acid; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; United States

2006
Dietary factors of one-carbon metabolism and prostate cancer risk.
    The American journal of clinical nutrition, 2006, Volume: 84, Issue:4

    Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Carbon; Case-Control Studies; Dietary Supplements; Double-Blind Method; Ethanol; Finland; Folic Acid; Humans; Male; Methionine; Middle Aged; One-Carbon Group Transferases; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6

2006
Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2008, Volume: 34, Issue:7

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Case-Control Studies; Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Spain

2008
Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:2

    Topics: Case-Control Studies; Chi-Square Distribution; Europe; Folic Acid; Humans; Incidence; Logistic Models; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Registries; Risk Factors; Surveys and Questionnaires; Vitamin B 12

2008
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
    Brain research, 1998, Jun-08, Volume: 795, Issue:1-2

    Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured

1998
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:9

    Topics: Antigens, Surface; Carboxypeptidases; Cell Fractionation; Cell Membrane; Folic Acid; gamma-Glutamyl Hydrolase; Glutamate Carboxypeptidase II; Humans; Hydrogen-Ion Concentration; Hydrolases; Immunohistochemistry; Male; Methotrexate; Polyglutamic Acid; Prostatic Neoplasms; Pteroylpolyglutamic Acids; Substrate Specificity; Tumor Cells, Cultured

1996
Transport of methotrexate into PC-3 human prostate cancer cells.
    Archives of biochemistry and biophysics, 2001, Oct-01, Volume: 394, Issue:1

    Topics: Binding, Competitive; Biological Transport, Active; Buffers; Carrier Proteins; Chlorides; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methotrexate; Prostatic Neoplasms; Tumor Cells, Cultured

2001
10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2002, Volume: 13, Issue:5

    Topics: Adenocarcinoma; Cell Division; Cell Line, Transformed; Down-Regulation; Folic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Liver Regeneration; Lung Neoplasms; Male; Oxidoreductases Acting on CH-NH Group Donors; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured

2002
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma.
    Scandinavian journal of clinical and laboratory investigation, 1992, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Estradiol Congeners; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Prostatic Neoplasms; Risk Factors; Vitamin B 12

1992
[Folate status and urinary folate excretion in malignant disease].
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974, Jul-13, Volume: 48, Issue:33

    Topics: Aged; Breast Neoplasms; Erythrocytes; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms

1974
A reconsideration of the biology of carcinoma of the prostate.
    British journal of urology, 1974, Volume: 46, Issue:1

    Topics: Anemia; Biopsy, Needle; Castration; Cholesterol; Diethylstilbestrol; Estrogens; Folic Acid; Hematuria; Humans; Iron; Lipoproteins; Lymph Nodes; Male; Neoplasm Metastasis; Prostatectomy; Prostatic Neoplasms; Prostatitis; Testosterone; Triglycerides; Uremia; Urination Disorders; Vitamin B 12

1974